Biomarker discordance: prospective and retrospective evidence that biopsy of recurrent disease is of clinical utility.

@article{Moussa2012BiomarkerDP,
  title={Biomarker discordance: prospective and retrospective evidence that biopsy of recurrent disease is of clinical utility.},
  author={Osama Moussa and C. Purdie and Sarah Vinnicombe and Alastair M. Thompson},
  journal={Cancer biomarkers : section A of Disease markers},
  year={2012},
  volume={12 6},
  pages={231-9}
}
Prospective studies of biomarker status in primary and recurrent or metastatic breast cancer have confirmed the findings of historical retrospective studies which demonstrate that for biomarkers which influence routine clinical practice, Estrogen Receptor (ER), Progesterone Receptor (PR) and Human Epidermal growth factor Receptor type 2 (HER2), biopsy of… CONTINUE READING